Treatment Outcomes of Intralesional Steroid Injection for Refractory Vocal Process Granuloma

ABSTRACT Objectives Vocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative treatment typically involves vocal hygiene education and antireflux medication. Treatment challenges arise with refractory cases. Outcomes of seco...

Full description

Saved in:
Bibliographic Details
Published inClinical otolaryngology Vol. 49; no. 6; pp. 822 - 826
Main Authors Yu, Po‐Jun, Hung, Wei‐Chen, Wang, Chi‐Te
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.11.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract ABSTRACT Objectives Vocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative treatment typically involves vocal hygiene education and antireflux medication. Treatment challenges arise with refractory cases. Outcomes of second‐line treatments such as surgical excision and botulinum toxin injections remain inconsistent. Thus, we propose this study to investigate the effectiveness of intralesional steroid injections for refractory VPG. Methods We conducted a retrospective review of 23 patients with VPG who showed no improvement after 3 months of proton pump inhibitors. These patients underwent one to three courses of monthly in‐office intralesional steroid injections as a second‐line therapy. Treatment outcomes were evaluated by measuring the size of the VPG relative to the length of the vocal folds before and after the final injection procedure. Results Results showed a significant reduction in VPG size from baseline of 27.74 ± 15.06 to 5.48 ± 8.95 (p < .001). 15 out of 23 patients were responsive (size reduction ≥ 75%) to intralesional steroid injection. Alcohol consumption and longer symptom duration were associated with a poor response (size reduction <75%), whereas prior intubation was associated with better response. Conclusions For refractory VPG not responding to conservative treatment, intralesional steroid injection appears to be a promising alternative option without significant adverse effects.
AbstractList ABSTRACT Objectives Vocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative treatment typically involves vocal hygiene education and antireflux medication. Treatment challenges arise with refractory cases. Outcomes of second‐line treatments such as surgical excision and botulinum toxin injections remain inconsistent. Thus, we propose this study to investigate the effectiveness of intralesional steroid injections for refractory VPG. Methods We conducted a retrospective review of 23 patients with VPG who showed no improvement after 3 months of proton pump inhibitors. These patients underwent one to three courses of monthly in‐office intralesional steroid injections as a second‐line therapy. Treatment outcomes were evaluated by measuring the size of the VPG relative to the length of the vocal folds before and after the final injection procedure. Results Results showed a significant reduction in VPG size from baseline of 27.74 ± 15.06 to 5.48 ± 8.95 (p < .001). 15 out of 23 patients were responsive (size reduction ≥ 75%) to intralesional steroid injection. Alcohol consumption and longer symptom duration were associated with a poor response (size reduction <75%), whereas prior intubation was associated with better response. Conclusions For refractory VPG not responding to conservative treatment, intralesional steroid injection appears to be a promising alternative option without significant adverse effects.
Vocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative treatment typically involves vocal hygiene education and antireflux medication. Treatment challenges arise with refractory cases. Outcomes of second-line treatments such as surgical excision and botulinum toxin injections remain inconsistent. Thus, we propose this study to investigate the effectiveness of intralesional steroid injections for refractory VPG. We conducted a retrospective review of 23 patients with VPG who showed no improvement after 3 months of proton pump inhibitors. These patients underwent one to three courses of monthly in-office intralesional steroid injections as a second-line therapy. Treatment outcomes were evaluated by measuring the size of the VPG relative to the length of the vocal folds before and after the final injection procedure. Results showed a significant reduction in VPG size from baseline of 27.74 ± 15.06 to 5.48 ± 8.95 (p < .001). 15 out of 23 patients were responsive (size reduction ≥ 75%) to intralesional steroid injection. Alcohol consumption and longer symptom duration were associated with a poor response (size reduction <75%), whereas prior intubation was associated with better response. For refractory VPG not responding to conservative treatment, intralesional steroid injection appears to be a promising alternative option without significant adverse effects.
ObjectivesVocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative treatment typically involves vocal hygiene education and antireflux medication. Treatment challenges arise with refractory cases. Outcomes of second‐line treatments such as surgical excision and botulinum toxin injections remain inconsistent. Thus, we propose this study to investigate the effectiveness of intralesional steroid injections for refractory VPG.MethodsWe conducted a retrospective review of 23 patients with VPG who showed no improvement after 3 months of proton pump inhibitors. These patients underwent one to three courses of monthly in‐office intralesional steroid injections as a second‐line therapy. Treatment outcomes were evaluated by measuring the size of the VPG relative to the length of the vocal folds before and after the final injection procedure.ResultsResults showed a significant reduction in VPG size from baseline of 27.74 ± 15.06 to 5.48 ± 8.95 (p < .001). 15 out of 23 patients were responsive (size reduction ≥ 75%) to intralesional steroid injection. Alcohol consumption and longer symptom duration were associated with a poor response (size reduction <75%), whereas prior intubation was associated with better response.ConclusionsFor refractory VPG not responding to conservative treatment, intralesional steroid injection appears to be a promising alternative option without significant adverse effects.
Vocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative treatment typically involves vocal hygiene education and antireflux medication. Treatment challenges arise with refractory cases. Outcomes of second-line treatments such as surgical excision and botulinum toxin injections remain inconsistent. Thus, we propose this study to investigate the effectiveness of intralesional steroid injections for refractory VPG.OBJECTIVESVocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative treatment typically involves vocal hygiene education and antireflux medication. Treatment challenges arise with refractory cases. Outcomes of second-line treatments such as surgical excision and botulinum toxin injections remain inconsistent. Thus, we propose this study to investigate the effectiveness of intralesional steroid injections for refractory VPG.We conducted a retrospective review of 23 patients with VPG who showed no improvement after 3 months of proton pump inhibitors. These patients underwent one to three courses of monthly in-office intralesional steroid injections as a second-line therapy. Treatment outcomes were evaluated by measuring the size of the VPG relative to the length of the vocal folds before and after the final injection procedure.METHODSWe conducted a retrospective review of 23 patients with VPG who showed no improvement after 3 months of proton pump inhibitors. These patients underwent one to three courses of monthly in-office intralesional steroid injections as a second-line therapy. Treatment outcomes were evaluated by measuring the size of the VPG relative to the length of the vocal folds before and after the final injection procedure.Results showed a significant reduction in VPG size from baseline of 27.74 ± 15.06 to 5.48 ± 8.95 (p < .001). 15 out of 23 patients were responsive (size reduction ≥ 75%) to intralesional steroid injection. Alcohol consumption and longer symptom duration were associated with a poor response (size reduction <75%), whereas prior intubation was associated with better response.RESULTSResults showed a significant reduction in VPG size from baseline of 27.74 ± 15.06 to 5.48 ± 8.95 (p < .001). 15 out of 23 patients were responsive (size reduction ≥ 75%) to intralesional steroid injection. Alcohol consumption and longer symptom duration were associated with a poor response (size reduction <75%), whereas prior intubation was associated with better response.For refractory VPG not responding to conservative treatment, intralesional steroid injection appears to be a promising alternative option without significant adverse effects.CONCLUSIONSFor refractory VPG not responding to conservative treatment, intralesional steroid injection appears to be a promising alternative option without significant adverse effects.
Author Yu, Po‐Jun
Hung, Wei‐Chen
Wang, Chi‐Te
Author_xml – sequence: 1
  givenname: Po‐Jun
  surname: Yu
  fullname: Yu, Po‐Jun
  organization: Far Eastern Memorial Hospital
– sequence: 2
  givenname: Wei‐Chen
  surname: Hung
  fullname: Hung, Wei‐Chen
  organization: Far Eastern Memorial Hospital
– sequence: 3
  givenname: Chi‐Te
  orcidid: 0000-0002-9999-1291
  surname: Wang
  fullname: Wang, Chi‐Te
  email: drwangct@gmail.com
  organization: University of Taipei
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39135379$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1KAzEUhYNU7I8ufAEZcKOLtskkncwsS9FaKFS0uhJCmrmBKTOTmmSQvr2pbV0UzSbh8p1D7jld1KpNDQhdEzwg4QyVkQPCYoLPUIdwlvUZS5PW75unbdR1bo0xo5iTC9SmGaEjyrMO-lhakL6C2keLxitTgYuMjma1t7IEV5haltGrB2uKPEzXoHyYRdrY6AW0lcobu43ejQrYszUKnIumVtZNaSp5ic61LB1cHe4eent8WE6e-vPFdDYZz_sq_AL3IeOJGsUEKFsxRqjCKc7SZKRVnuBYcqAxxbnKIV3pVGOuwqo85ynRNE8lX9Eeutv7bqz5bMB5URVOQVnKGkzjBMVZTJMRTUhAb0_QtWlsWDJQhMQJ4zyJA3VzoJpVBbnY2KKSdiuOuQVguAeUNc5Z0EIVXu6iCbkVpSBY7JoRoRnx00xQ3J8ojqZ_sQf3r6KE7f-gmCzGe8U324WbxQ
CitedBy_id crossref_primary_10_1111_coa_14229
Cites_doi 10.1016/j.jvoice.2015.07.015
10.1016/j.amjoto.2017.01.039
10.1017/S0022215107000710
10.1002/hed.21091
10.1177/000348941011900509
10.1111/coa.12021
10.4103/sja.SJA_543_18
10.1007/978-981-16-3303-4_17
10.1177/0003489414525921
10.1093/alcalc/agy063
ContentType Journal Article
Copyright 2024 John Wiley & Sons Ltd.
Copyright_xml – notice: 2024 John Wiley & Sons Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
8FD
FR3
K9.
M7Z
P64
7X8
DOI 10.1111/coa.14210
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biochemistry Abstracts 1
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Biochemistry Abstracts 1
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE
Biochemistry Abstracts 1
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1749-4486
EndPage 826
ExternalDocumentID 39135379
10_1111_coa_14210
COA14210
Genre perspective
Journal Article
GrantInformation_xml – fundername: Far Eastern Memorial Hospital
  funderid: FEMH‐2023‐C‐025
– fundername: Far Eastern Memorial Hospital
  grantid: FEMH-2023-C-025
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1OC
29B
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5RE
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
Q~Q
R.K
RJQFR
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
ZGI
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
FR3
K9.
M7Z
P64
7X8
ID FETCH-LOGICAL-c3530-e976c521e34b4413c0809865fcd602a7e3230dcde8bf8f07c4217d781f3d8a7b3
IEDL.DBID DR2
ISSN 1749-4478
1749-4486
IngestDate Fri Jul 11 12:25:37 EDT 2025
Sat Jul 26 01:02:19 EDT 2025
Thu Apr 03 07:04:24 EDT 2025
Tue Jul 01 02:40:32 EDT 2025
Thu Apr 24 23:09:15 EDT 2025
Wed Jan 22 17:16:13 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords voice
contact ulcer
minimally invasive surgery
proton pump inhibitor
contact granuloma
laryngopharyngeal reflux
Language English
License 2024 John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3530-e976c521e34b4413c0809865fcd602a7e3230dcde8bf8f07c4217d781f3d8a7b3
Notes This study was supported by funds from Far Eastern Memorial Hospital (FEMH‐2023‐C‐025).
Po‐Jun Yu and Wei‐Chen Hung are equal contributors to this work and designated as co‐first authors.
Correction added on 2 October 2024, after first online publication: The abstract section has been removed in this version.
Funding
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-9999-1291
PMID 39135379
PQID 3112647762
PQPubID 36531
PageCount 5
ParticipantIDs proquest_miscellaneous_3092365361
proquest_journals_3112647762
pubmed_primary_39135379
crossref_citationtrail_10_1111_coa_14210
crossref_primary_10_1111_coa_14210
wiley_primary_10_1111_coa_14210_COA14210
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2024
2024-11-00
2024-Nov
20241101
PublicationDateYYYYMMDD 2024-11-01
PublicationDate_xml – month: 11
  year: 2024
  text: November 2024
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Clinical otolaryngology
PublicationTitleAlternate Clin Otolaryngol
PublicationYear 2024
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2016; 30
2013; 38
2009; 31
2010; 119
2008; 122
2021
2017; 38
2019; 54
2019; 13
2014; 123
e_1_2_9_11_1
e_1_2_9_10_1
e_1_2_9_9_1
e_1_2_9_8_1
e_1_2_9_7_1
e_1_2_9_6_1
e_1_2_9_5_1
e_1_2_9_4_1
e_1_2_9_3_1
e_1_2_9_2_1
References_xml – volume: 123
  start-page: 314
  year: 2014
  end-page: 320
  article-title: Vocal Process Granulomas: A Systematic Review of Treatment
  publication-title: Annals of Otology, Rhinology and Laryngology
– volume: 30
  start-page: 741
  year: 2016
  end-page: 743
  article-title: Botulinum Toxin A for Treatment of Contact Granuloma
  publication-title: Journal of Voice
– volume: 122
  start-page: 824
  year: 2008
  end-page: 828
  article-title: Botulinum Toxin as Adjunctive Therapy in Refractory Laryngeal Granuloma
  publication-title: Journal of Laryngology and Otology
– volume: 54
  start-page: 62
  year: 2019
  end-page: 69
  article-title: Alcohol Consumption and the Risk of Gastroesophageal Reflux Disease: A Systematic Review and Meta‐Analysis
  publication-title: Alcohol and Alcoholism
– volume: 31
  start-page: 1309
  year: 2009
  end-page: 1315
  article-title: Endoscopic Nasopharyngectomy With Potassium‐Titanyl‐Phosphate (KTP) Laser for Early Locally Recurrent Nasopharyngeal Carcinoma
  publication-title: Head & Neck
– volume: 119
  start-page: 325
  year: 2010
  end-page: 330
  article-title: Inhaled Triamcinolone With Proton Pump Inhibitor for Treatment of Vocal Process Granulomas: A Series of 67 Granulomas
  publication-title: Annals of Otology, Rhinology and Laryngology
– volume: 38
  start-page: 77
  year: 2013
  end-page: 81
  article-title: Intralesional Steroid Injection: An Alternative Treatment Option for Vocal Process Granuloma in Ten Patients
  publication-title: Clinical Otolaryngology
– volume: 13
  year: 2019
  article-title: The STROBE Guidelines
  publication-title: Saudi Journal of Anaesthesia
– volume: 38
  start-page: 593
  year: 2017
  end-page: 597
  article-title: Comparison of the Effects of Esomeprazole Plus Mosapride Citrate and Botulinum Toxin A on Vocal Process Granuloma
  publication-title: American Journal of Otolaryngology
– year: 2021
– ident: e_1_2_9_8_1
  doi: 10.1016/j.jvoice.2015.07.015
– ident: e_1_2_9_9_1
  doi: 10.1016/j.amjoto.2017.01.039
– ident: e_1_2_9_7_1
  doi: 10.1017/S0022215107000710
– ident: e_1_2_9_10_1
  doi: 10.1002/hed.21091
– ident: e_1_2_9_3_1
  doi: 10.1177/000348941011900509
– ident: e_1_2_9_5_1
  doi: 10.1111/coa.12021
– ident: e_1_2_9_6_1
  doi: 10.4103/sja.SJA_543_18
– ident: e_1_2_9_4_1
  doi: 10.1007/978-981-16-3303-4_17
– ident: e_1_2_9_2_1
  doi: 10.1177/0003489414525921
– ident: e_1_2_9_11_1
  doi: 10.1093/alcalc/agy063
SSID ssj0043071
Score 2.3894012
Snippet ABSTRACT Objectives Vocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative...
Vocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative treatment typically...
ObjectivesVocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative treatment...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 822
SubjectTerms Adult
Aged
Botulinum toxin
Clinical outcomes
contact granuloma
contact ulcer
Female
Glucocorticoids - administration & dosage
Granuloma
Granuloma, Laryngeal - drug therapy
Granulomas
Humans
Hygiene
Injection
Injections, Intralesional
Laryngeal Diseases - drug therapy
laryngopharyngeal reflux
Male
Middle Aged
minimally invasive surgery
proton pump inhibitor
Proton pump inhibitors
Retrospective Studies
Size reduction
Steroids
Treatment Outcome
Vocal Cords - injuries
voice
Title Treatment Outcomes of Intralesional Steroid Injection for Refractory Vocal Process Granuloma
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcoa.14210
https://www.ncbi.nlm.nih.gov/pubmed/39135379
https://www.proquest.com/docview/3112647762
https://www.proquest.com/docview/3092365361
Volume 49
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hDohLC7TQhQW5VQ-9BG3iJHbEabViC0gLEgXEASnyU-KVoN3NAX49Y-chaKmEuEXJJH7MTOYbe2YM8JOyRAthw8BKlQUxt1EgqQ4DhV5cxDVaROnWISfH6cF5fHSZXC7AXpsLU9eH6BbcnGb4_7VTcCFnL5RclQLVPPLpVS5WywGi0650VIyyG9bJkNiFmPGmqpCL4unefG2L_gGYr_GqNzjjz3DVdrWOM7ndreZyVz39VcXxg2NZgU8NECXDWnJWYcEUa7A0abbav8DVWRuCTk6qOX7QzEhpyaFfDDZ1LQ_yB7lSXmu8e-NDugqCGJicGjv1x_g8kgtnKkmTjUB-o2Gs7sp78RXOx_tno4OgOYohUDShg8AgalFo6Q2NJQIo6uqTZzxNrNLpIBLMUHRltNKGS8vtgCkcDNOMh5ZqLpik67BYlIX5BgQRD3eoTCdcxSZSGaM6CZlCKISupVA9-NUyJVdNnXJ3XMZd3vorOFu5n60e_OhIH-riHG8R9VvO5o1-znLqMqdihpagB9-7x6hZbrtEFKaskGaA4DdNaBr2YKOWiK4VmrnzQliGnfV8_X_z-ehk6C8230-6BcsRYqc65bEPi_NpZbYR-8zljhfyZy28_cU
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LT9wwEB5RKrVcaGkLLIXiVq3US9AmTmLnwAHx6C6wIMFScUAKiR8SrwSxGyH4TfwV_hNj5yFoQeLCgVuUWHFsz3i-cWa-AfhJWSCTRLuOTkXk-Fx7Tkql6wj04jwu0SKm5hyytxV29vz1_WB_BG7qXJiSH6I5cDOaYfdro-DmQPqelos8QT1Hl6UKqdxQV5fosA0Wuyu4ur88b221v9xxqpoCjqABbTsKza9Ak6WonyISoIZoO-JhoIUM217CFEVMLoVUPNVct5nADphk3NVU8oSlFN_7Bt6aCuKGqX9lpyGr8lFb3DL9EgftM17xGJm4oeZTH1q__yDtQ4RsTdzaB7itJ6eMbDlZKIbpgrj-hzfytczeRxivsDZZKpVjAkZU9gne9apogs9w0K-j7Ml2McQRqAHJNena825V0pWQXRS8_Eji3WMbtZYRhPlkR-kLW6noivw1aIBUCRfkD9r-4jQ_S77A3ouMbRJGszxT00AQ1HEDPGXAha88ETEqA5cJRHvoPSeiBb9rKYhFRcVuKoKcxrVLhqsT29VpwY-m6XnJP_JYo9lalOJqCxrE1CSH-QyNXQu-N49x8zB_hJJM5QW2aSO-DwMaui2YKkWw6YVGpiQKi_BjrSA93X28vL1kL2ae33Qe3nf6vc14s7u18RXGPISKZYbnLIwOLwo1h1BvmH6zGkbg8KWF8g5a_1qB
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1JT90wEB5RkFAvbG3hsdWtWqmXoCROYufAAfF48KBARaHigBQSLxJbgngvQvCX-Cv8KMbOotJF6oVDb1FixbE94_nGmfkG4BNloUxT7Tk6E7ETcO07GZWeI9CL87lEi5iZc8jdvWjrKNg-Do9H4KHJhan4IdoDN6MZdr82Cn4t9U9KLooU1Rw9ljqickfd3aK_Nljtd3FxP_t-b-NwfcupSwo4gobUdRRaX4EWS9EgQyBADc92zKNQCxm5fsoURUguhVQ801y7TGAHTDLuaSp5yjKK730FY0HkxqZORPeg5aoKUFm8KvsSxxwwXtMYmbCh9lOfG7_fEO1zgGwtXG8SHpu5qQJbLlbKYbYi7n-hjfxPJm8KJmqkTdYq1ZiGEZXPwPhuHUvwBk4Omxh7sl8OcQBqQApN-va0W1VkJeQ7il1xJvHuuY1ZywmCfHKg9I2tU3RHfhgsQOp0C7KJlr-8LK7St3D0ImN7B6N5kas5IAjpuIGdMuQiUL6IGZWhxwRiPfSdU9GBL40QJKImYjf1QC6TxiHD1Uns6nTgY9v0umIf-VOjxUaSknoDGiTUpIYFDE1dBz60j3HrMP-D0lwVJbZxEd1HIY28DsxWEtj2QmNTEIXF-LFWjv7efbK-v2Yv5v-96XsY_9btJV_7ezsL8NpHnFildy7C6PCmVEuI84bZstUvAqcvLZNP0NdZMA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Treatment+Outcomes+of+Intralesional+Steroid+Injection+for+Refractory+Vocal+Process+Granuloma&rft.jtitle=Clinical+otolaryngology&rft.au=Yu%2C+Po%E2%80%90Jun&rft.au=Hung%2C+Wei%E2%80%90Chen&rft.au=Wang%2C+Chi%E2%80%90Te&rft.date=2024-11-01&rft.issn=1749-4478&rft.eissn=1749-4486&rft.volume=49&rft.issue=6&rft.spage=822&rft.epage=826&rft_id=info:doi/10.1111%2Fcoa.14210&rft.externalDBID=10.1111%252Fcoa.14210&rft.externalDocID=COA14210
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1749-4478&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1749-4478&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1749-4478&client=summon